Gemcitabine-capecitabine: a therapeutic option in previously treated advanced primary pulmonary lymphoepithelioma-like carcinoma.
作者信息
Pons-Tostivint Elvire
机构信息
Department of Medical Oncology, Nantes Université, CHU Nantes, Nantes, France.
Inserm UMR 1307, CNRS UMR 6075, CRCI2NA, Nantes, France.
出版信息
Transl Lung Cancer Res. 2023 Jun 30;12(6):1143-1146. doi: 10.21037/tlcr-23-173. Epub 2023 Jun 2.
Abstract
摘要
相似文献
1
Gemcitabine-capecitabine: a therapeutic option in previously treated advanced primary pulmonary lymphoepithelioma-like carcinoma.吉西他滨-卡培他滨：既往接受过治疗的晚期原发性肺淋巴上皮瘤样癌的一种治疗选择。
Transl Lung Cancer Res. 2023 Jun 30;12(6):1143-1146. doi: 10.21037/tlcr-23-173. Epub 2023 Jun 2.
2
Efficacy and safety of gemcitabine and capecitabine combination for patients with previously treated advanced primary pulmonary lymphoepithelioma-like carcinoma: a retrospective single-arm cohort study.吉西他滨与卡培他滨联合用药治疗既往接受过治疗的晚期原发性肺淋巴上皮瘤样癌患者的疗效与安全性：一项回顾性单臂队列研究
Transl Lung Cancer Res. 2023 Jan 31;12(1):96-108. doi: 10.21037/tlcr-22-256. Epub 2023 Jan 16.
3
First-line platinum-based chemotherapy and survival outcomes in locally advanced or metastatic pulmonary lymphoepithelioma-like carcinoma.一线铂类化疗与局部晚期或转移性肺淋巴上皮瘤样癌的生存结局。
Lung Cancer. 2019 Nov;137:100-107. doi: 10.1016/j.lungcan.2019.09.007. Epub 2019 Sep 12.
4
Capecitabine as salvage treatment for lymphoepithelioma-like carcinoma of lung.卡培他滨作为肺淋巴上皮瘤样癌的挽救性治疗手段。
J Thorac Oncol. 2009 Sep;4(9):1174-7. doi: 10.1097/JTO.0b013e3181b28f15.
5
Comparison of efficacy and safety of three induction chemotherapy regimens with gemcitabine plus cisplatin (GP), cisplatin plus fluorouracil (PF) and cisplatin plus capecitabine (PX) for locoregionally advanced previously untreated nasopharyngeal carcinoma: A pooled analysis of two prospective studies.三种以吉西他滨联合顺铂（GP）、顺铂联合氟尿嘧啶（PF）和顺铂联合卡培他滨（PX）为方案的诱导化疗方案治疗局部晚期初治鼻咽癌的疗效和安全性比较：两项前瞻性研究的汇总分析。
Oral Oncol. 2021 Mar;114:105158. doi: 10.1016/j.oraloncology.2020.105158. Epub 2021 Jan 25.
6
Optimizing the administration of fixed-dose rate gemcitabine plus capecitabine using an alternating-week schedule: a dose finding and early efficacy study in advanced pancreatic and biliary carcinomas.优化固定剂量率吉西他滨联合卡培他滨的给药方案：一项在晚期胰腺和胆道癌中进行的剂量探索和早期疗效研究。
Am J Clin Oncol. 2012 Oct;35(5):411-7. doi: 10.1097/COC.0b013e3182185888.
7
Mitomycin C in combination with capecitabine or biweekly high-dose gemcitabine in patients with advanced biliary tract cancer: a randomised phase II trial.丝裂霉素C联合卡培他滨或每两周一次大剂量吉西他滨治疗晚期胆管癌患者：一项随机II期试验
Ann Oncol. 2004 Mar;15(3):478-83. doi: 10.1093/annonc/mdh096.
8
Capecitabine combined with gemcitabine (CapGem) as first-line treatment in patients with advanced/metastatic biliary tract carcinoma.卡培他滨联合吉西他滨（CapGem）用于晚期/转移性胆管癌患者的一线治疗。
Cancer. 2005 Dec 15;104(12):2753-8. doi: 10.1002/cncr.21591.
9
Capecitabine plus erlotinib in gemcitabine-refractory advanced pancreatic cancer.卡培他滨联合厄洛替尼治疗吉西他滨难治性晚期胰腺癌。
J Clin Oncol. 2007 Oct 20;25(30):4787-92. doi: 10.1200/JCO.2007.11.8521.
10
Oral chemotherapy for second-line treatment in patients with gemcitabine-refractory advanced pancreatic cancer.吉西他滨难治性晚期胰腺癌患者二线治疗的口服化疗
World J Gastrointest Oncol. 2019 Nov 15;11(11):1021-1030. doi: 10.4251/wjgo.v11.i11.1021.
本文引用的文献
1
Efficacy and safety of gemcitabine and capecitabine combination for patients with previously treated advanced primary pulmonary lymphoepithelioma-like carcinoma: a retrospective single-arm cohort study.吉西他滨与卡培他滨联合用药治疗既往接受过治疗的晚期原发性肺淋巴上皮瘤样癌患者的疗效与安全性：一项回顾性单臂队列研究
Transl Lung Cancer Res. 2023 Jan 31;12(1):96-108. doi: 10.21037/tlcr-22-256. Epub 2023 Jan 16.
2
PD-1 inhibition plus platinum-based chemotherapy (PBC) or PBC alone in the first-line treatment of locally advanced or metastatic pulmonary lymphoepithelioma-like carcinoma.PD-1 抑制剂联合铂类化疗（PBC）或 PBC 单独用于局部晚期或转移性肺淋巴上皮瘤样癌的一线治疗。
Front Immunol. 2022 Sep 29;13:1015444. doi: 10.3389/fimmu.2022.1015444. eCollection 2022.
3
Comparison of Immunotherapy, Chemotherapy, and Chemoimmunotherapy in Advanced Pulmonary Lymphoepithelioma-Like Carcinoma： A Retrospective Study.晚期肺淋巴上皮瘤样癌的免疫治疗、化疗及化疗免疫治疗比较：一项回顾性研究
Front Oncol. 2022 Feb 14;12:820302. doi: 10.3389/fonc.2022.820302. eCollection 2022.
4
The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015.2021 年世卫组织肺肿瘤分类：自 2015 年以来的进展影响。
J Thorac Oncol. 2022 Mar;17(3):362-387. doi: 10.1016/j.jtho.2021.11.003. Epub 2021 Nov 20.
5
Molecular characteristics of primary pulmonary lymphoepithelioma-like carcinoma based on integrated genomic analyses.基于综合基因组分析的原发性肺淋巴上皮瘤样癌的分子特征。
Signal Transduct Target Ther. 2021 Jan 8;6(1):6. doi: 10.1038/s41392-020-00382-6.
6
Primary pulmonary lymphoepithelioma-like carcinoma.原发性肺淋巴上皮瘤样癌。
Med Oncol. 2020 Mar 7;37(3):20. doi: 10.1007/s12032-020-1344-3.
7
Low frequency of mutation of epidermal growth factor receptor (EGFR) and arrangement of anaplastic lymphoma kinase (ALK) in primary pulmonary lymphoepithelioma-like carcinoma.原发性肺淋巴上皮瘤样癌中表皮生长因子受体（EGFR）突变和间变性淋巴瘤激酶（ALK）排列的低频性。
Thorac Cancer. 2020 Feb;11(2):346-352. doi: 10.1111/1759-7714.13271. Epub 2019 Dec 3.
8
Thorough survey and analysis of pulmonary lymphoepithelioma-like carcinoma in Macau and multimodality treatment for advanced disease.对澳门地区肺淋巴上皮瘤样癌的全面调查和分析，以及晚期疾病的多模态治疗。
Lung Cancer. 2019 Dec;138:116-123. doi: 10.1016/j.lungcan.2019.10.004. Epub 2019 Oct 11.
9
First-line platinum-based chemotherapy and survival outcomes in locally advanced or metastatic pulmonary lymphoepithelioma-like carcinoma.一线铂类化疗与局部晚期或转移性肺淋巴上皮瘤样癌的生存结局。
Lung Cancer. 2019 Nov;137:100-107. doi: 10.1016/j.lungcan.2019.09.007. Epub 2019 Sep 12.
10
Clinical Features and Prognosis of Pulmonary Lymphoepithelioma-like Carcinoma: Summary of Eighty-five Cases.肺淋巴上皮瘤样癌的临床特征和预后：85 例总结。
Clin Lung Cancer. 2019 May;20(3):e329-e337. doi: 10.1016/j.cllc.2018.12.014. Epub 2018 Dec 24.
Zotero 插件